What is Summit Therapeutics?
Summit Therapeutics is an international biopharmaceutical company dedicated to the discovery and development of innovative medicines. Headquartered in Cambridge, UK, the company's primary focus is on addressing Duchenne muscular dystrophy, a rare and debilitating genetic disorder. By leveraging cutting-edge research and development, Summit Therapeutics aims to create therapeutic solutions for patients with significant unmet medical needs.
How much funding has Summit Therapeutics raised?
Summit Therapeutics has raised a total of $1.2B across 4 funding rounds:
Stock Offering
$34.2M
Share Placement
$200M
Stock/Share Issuance
$500M
Stock/Share Issuance
$500M
Stock Issuance/Offering (2015): $34.2M, investors not publicly disclosed
Share Placement (2024): $200M, investors not publicly disclosed
Stock/Share Issuance (2025): $500M supported by Akeso
Stock/Share Issuance (2025): $500M featuring Akeso
Key Investors in Summit Therapeutics
Akeso
Akeso, Inc is a pioneering biopharmaceutical company focused on the research and development of innovative antibody drugs for major diseases such as cancer, autoimmune disorders, and metabolic diseases. The company has developed a unique end-to-end drug research and development platform known as the ACE Platform, which incorporates advanced technologies like Tetrabody and Dual-Shield ADCT. With a commitment to addressing unmet clinical needs globally, Akeso aims to provide affordable innovative antibody drug solutions while creating significant commercial and social value. The company actively seeks strategic partnerships for collaborative product development and licensing both in China and internationally.
What's next for Summit Therapeutics?
The recent major strategic investment signals a pivotal stage for Summit Therapeutics, likely indicating a move towards scaling operations and advancing its drug pipeline towards late-stage clinical trials and potential commercialization. This substantial backing from investors will be crucial for navigating the complex and capital-intensive biopharmaceutical development process, enabling the company to further its mission of bringing life-changing therapies to market.
See full Summit Therapeutics company page
